Source · Select Committees · Science and Technology Committee (Commons)
Recommendation 16
16
Paragraph: 84
Establish a publicly-funded GMP facility for phage production and address industry investment barriers
Recommendation
We recommend that the Department for Health and Social Care considers bringing together funders with relevant catapults and innovation centres, such as the Centre The antimicrobial potential of bacteriophages 59 for Process Innovation, to build a GMP facility that can be accessed and used by phage innovators, the NHS and those seeking to produce microbiome products. The Government should also consider investment in existing spare and disused laboratory space, such as the currently for sale Rosalind Franklin Laboratory, to develop a GMP facility for phage production. In addition, the Government should consider why there is a reluctance by pharmaceutical companies to invest in phages, and what steps it can take to address this.
Paragraph Reference:
84
Government Response
A response document is linked to this report, dated 1 March 2024. Response attribution to this recommendation has not been verified. Read the response document ↗